Aurora Cannabis (ACB) Preferred Stock Liabilities (2018)
Aurora Cannabis (ACB) reported Preferred Stock Liabilities of $298.2 million for Q4 2018, up 75.09% quarter-over-quarter from $170.3 million in Q2 2018.
Aurora Cannabis (ACB) Preferred Stock Liabilities (2018) Analysis & Trends
Aurora Cannabis (ACB) has 1 years of Preferred Stock Liabilities data on file, last reported at $298.2 million in Q4 2018.
- Preferred Stock Liabilities for Q4 2018 came in at $298.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $298.2 million (changed N/A YoY), and the FY2018 annual result was $170.3 million, changed N/A from the prior year.
- Preferred Stock Liabilities rose to $298.2 million in Q4 2018 per ACB's latest filing, from $170.3 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $298.2 million in Q4 2018 and troughed at $170.3 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 298.18 Mn |
| Jun 30, 2018 | 170.30 Mn |